查看购物车
  • Traditional Chinese
  • English
2030 年亚太地区生物分析测试服务市场预测 - 区域分析 - 按服务分类；疾病适应症；和最终用户
市场调查报告书
商品编码
1463675

2030 年亚太地区生物分析测试服务市场预测 - 区域分析 - 按服务分类；疾病适应症；和最终用户

Asia Pacific Bioanalytical Testing Services Market Forecast to 2030 - Regional Analysis - by Services ; Disease Indication ; and End User
出版日期: | 出版商: The Insight Partners | 英文 114 Pages | 订单完成后即时交付

价格

2022年亚太生物分析测试服务市值为10.0433亿美元，预计2030年将达到22.5288亿美元；预计2022年至2030年CAGR为10.6%。

製药业公司不间断的成长推动了亚太生物分析测试服务市场

药品及其他医药产品的研发、生产及销售是医药工业的主要领域。随着治疗年龄相关疾病和慢性病的药物需求增加，全球药品消费量也不断增加。根据世界卫生组织预测，从2020年到2050年，60岁或以上的老年人口预计将增加一倍，到2050年将达到约21亿。疾病、癌症、高血压、骨关节炎和糖尿病。因此，慢性病一直是製药公司关注的主要领域。

新药开发是一个资源、成本和时间密集的过程，后期的临床阶段会导致巨大的成本。多家製药公司选择生物分析测试服务来进行药物开发以及临床和临床前阶段的检测验证。仿製药和品牌药物化合物大多是小分子。仿製药製造商进行并提交生物分析测试结果，以克服专利到期的问题。因此，随着製药业的不断发展，生物分析检测服务提供者未来的服务需求可能会持续成长，这将为生物分析检测服务市场带来新的成长机会。

亚太地区生物分析测试服务市场概况

亚太地区生物分析测试服务市场分为中国、日本、印度、韩国、澳洲和亚太地区其他地区。由于低成本劳动力市场对外包服务的需求不断增加，预计亚太地区生物分析测试服务市场将在研究期间出现最高成长。印尼、印度和中国的交付中心通常支援该地区的外包服务。中国作为日本在岸和离岸客户的交货地点越来越受欢迎。此外，该地区各国政府越来越重视预防传染病的传播，为生物分析测试服务市场的扩张做出了巨大贡献。例如，卫生部、当地大学和非政府组织（NGO）确保这项能力建设措施的持续支持和永续性。实施研究培训是基于印度太平洋地区监测和回应的更广泛合作研究计画的一部分 - “热带卫生合作伙伴”计画。

亚太地区生物分析测试服务市场收入及 2030 年预测（百万美元）

亚太地区生物分析测试服务市场细分

亚太地区生物分析测试服务市场根据测试类型、疾病适应症、最终用户和国家进行细分。

根据测试类型，亚太地区生物分析测试服务市场分为药物动力学、生物标记、免疫原性、病毒学测试、细胞分析等。 2022 年，基于细胞的检测领域占据最大的市场份额。

根据疾病指示，亚太生物分析测试服务市场分为心血管、神经系统疾病、代谢失调、呼吸系统疾病、自体免疫疾病、肿瘤、性健康、骨骼疾病等。 2022 年，肿瘤学领域占据最大的市场。

根据最终用户，亚太地区生物分析测试服务市场分为製药和生物製药公司、合约研究组织（CRO）、合约开发和製造组织（CDMO）等。 2022 年，製药和生物製药公司领域占据最大的市场份额。

按国家/地区划分，亚太地区生物分析测试服务市场分为中国、日本、印度、澳洲、韩国和亚太地区其他地区。 2022年，中国在亚太生物分析测试服务市场份额中占据主导地位。

SGS SA、康龙化成北京有限公司、Element Materials Technology Group Ltd、Charles River Laboratories International Inc、Eurofins Scientific SE、Labcorp Drug Development Inc、Syneos Health Inc、ICON Plc 和 Intertek Group Plc 是在亚洲运营的一些领先公司太平洋生物分析测试服务市场。

目录

表中的内容

第 1 章：简介

第 2 章：执行摘要

  • 重要见解

第 3 章：研究方法

  • 覆盖范围
  • 二次研究
  • 初步研究

第 4 章：亚太地区生物分析测试服务市场格局

  • 概述
  • PEST分析
    • 亚太地区 PEST 分析

第 5 章：亚太地区生物分析测试服务市场 - 主要产业动态

  • 主要市场驱动因素：
    • 药厂增加研发活动外包
    • 对生物相似药和生物製剂分析测试的高需求
  • 主要市场限制：
    • 与生物分析测试服务相关的高成本
  • 主要市场机会
    • 医药产业持续成长
  • 未来的趋势
    • 针对新兴罕见疾病的药物发现和开发活动不断增加
  • 影响分析：

第 6 章：生物分析测试服务市场 - 亚太市场分析

  • 生物分析测试服务市场收入，2022 - 2030

第 7 章：亚太地区生物分析测试服务市场 - 收入和 2030 年预测 - 按服务分类

  • 概述
  • 2022 年和 2030 年生物分析测试服务市场收入份额（按服务划分）（%）
  • 药物动力学
  • 生物标誌物
  • 免疫原性
  • 病毒学检测
  • 基于细胞的检测
  • 其他的

第 8 章：亚太地区生物分析测试服务市场 - 收入和 2030 年预测 - 按疾病适应症

  • 概述
  • 2022 年和 2030 年按疾病适应症分類的生物分析测试服务市场收入份额 (%)
  • 心血管
  • 神经系统疾病
  • 自体免疫疾病
  • 呼吸疾病
  • 代谢紊乱
  • 肿瘤学
  • 性健康
  • 骨病
  • 其他的

第 9 章：亚太地区生物分析测试服务市场 - 收入和 2030 年预测 - 按最终用户

  • 概述
  • 2022 年和 2030 年生物分析测试服务市场收入份额（按最终用户划分）（%）
  • 製药和生物製药公司
  • 合约研究组织（CRO）
  • 合约开发与製造组织 (CDMO)
  • 其他的

第 10 章：亚太地区生物分析测试服务市场 - 国家分析

  • 中国
  • 日本
  • 印度
  • 澳洲
  • 韩国
  • 亚太地区其他地区

第 11 章：生物分析测试服务市场产业格局

  • 概述
  • 生物分析测试服务市场的成长策略
  • 无机成长策略
    • 概述
  • 有机成长策略
    • 概述

第 12 章：公司简介

  • SGS SA
  • Pharmaron Beijing Co Ltd
  • Element Materials Technology Group Ltd
  • Charles River Laboratories International Inc
  • Eurofins Scientific SE
  • Labcorp Drug Development Inc
  • Syneos Health Inc
  • ICON Plc
  • Intertek Group Plc

第 13 章：附录

Product Code: BMIRE00029556

The Asia Pacific bioanalytical testing services market was valued at US$ 1,004.33 million in 2022 and is expected to reach US$ 2,252.88 million by 2030; it is estimated to grow at a CAGR of 10.6% from 2022 to 2030.

Uninterrupted Growth of Pharmaceuticals Industry Companies Fuel the Asia Pacific Bioanalytical Testing Services Market

The research & development, production, and distribution of medicinal drugs and other pharmaceutical products are the major areas of the pharmaceutical industry. Global pharmaceutical consumption is rising with the increasing need for drugs to treat age-related diseases and chronic diseases. According to the WHO, the elderly population aged 60 or above is projected to double from 2020 to 2050, reaching ~2.1 billion by 2050. A rise in the geriatric population would contribute to a surge in incidences of chronic diseases, such as cardiovascular diseases, cancer, hypertension, osteoarthritis, and diabetes mellitus. Thus, chronic diseases have been a major area of focus for pharmaceutical companies.

New drug development is a resource-, cost-, and time-intensive process, where later clinical stages result in significant costs. Several pharmaceutical companies are opting for bioanalytical testing services for drug development and validation of assays in both clinical and preclinical stages. Generics and branded drug compounds are mostly small molecules. Generics manufacturers conduct and submit bioanalytical testing results to overcome the issue of patent expiration. Thus, with the uninterrupted proliferation of the pharmaceutical industry, bioanalytical testing service providers are likely to experience a continuous rise in demand for their services in the future, which would lead to new growth opportunity in the bioanalytical testing services market.

Asia Pacific Bioanalytical Testing Services Market Overview

The Asia Pacific bioanalytical testing services market is segmented into China, Japan, India, South Korea, Australia, and the Rest of Asia Pacific. The Asia Pacific bioanalytical testing services market is expected to witness the highest growth during the study period due to the increasing demand for outsourcing services in the low-cost labor markets. Delivery centers in Indonesia, India, and China typically support outsourcing services in this region. China is gaining popularity as a delivery location for both onshore and offshore customers based in Japan. Additionally, governments across the region place increasing importance on preventing the spread of infectious diseases, contributing significantly to the expansion of the bioanalytical testing services market. For instance, Ministries of Health, local universities, and Non-Governmental Organizations (NGOs) to ensure continued support and sustainability of this capacity-building initiative. The implementation research training was part of a broader program of collaborative research projects based on surveillance and response in the Indo-Pacific region - the "Partners in Tropical Health" project.

Asia Pacific Bioanalytical Testing Services Market Revenue and Forecast to 2030 (US$ Million)

Asia Pacific Bioanalytical Testing Services Market Segmentation

The Asia Pacific bioanalytical testing services market is segmented based on test type, disease indication, end user, and country.

Based on test type, the Asia Pacific bioanalytical testing services market is segmented into pharmacokinetics, biomarkers, immunogenicity, virology testing, cell-based assays, and others. The cell-based assays segment held the largest market share in 2022.

Based on disease indication, the Asia Pacific bioanalytical testing services market is segmented into cardiovascular, neurological disorders, metabolic disorders, respiratory diseases, autoimmune disorder, oncology, sexual health, bone disease, and others. The oncology segment held the largest market share in 2022.

Based on end user, the Asia Pacific bioanalytical testing services market is segmented into pharmaceutical and biopharmaceutical companies, contract research organization (CRO), contract development and manufacturing organization (CDMO), and others. The pharmaceutical and biopharmaceutical companies segment held the largest market share in 2022.

Based on country, the Asia Pacific bioanalytical testing services market is segmented into China, Japan, India, Australia, South Korea, and the Rest of Asia Pacific. China dominated the Asia Pacific bioanalytical testing services market share in 2022.

SGS SA, Pharmaron Beijing Co Ltd, Element Materials Technology Group Ltd, Charles River Laboratories International Inc, Eurofins Scientific SE, Labcorp Drug Development Inc, Syneos Health Inc, ICON Plc, and Intertek Group Plc are some of the leading companies operating in the Asia Pacific bioanalytical testing services market.

Table Of Contents

Table of Content

1. Introduction

  • 1.1 The Insight Partners Research Report Guidance
  • 1.2 Market Segmentation

2. Executive Summary

  • 2.1 Key Insights

3. Research Methodology

  • 3.1 Coverage
  • 3.2 Secondary Research
  • 3.3 Primary Research

4. Asia Pacific Bioanalytical Testing Services Market Landscape

  • 4.1 Overview
  • 4.2 PEST Analysis
    • 4.2.1 Asia Pacific PEST Analysis

5. Asia Pacific Bioanalytical Testing Services Market - Key Industry Dynamics

  • 5.1 Key Market Drivers:
    • 5.1.1 Increasing Outsourcing of R&D Activities by Pharmaceutical Companies
    • 5.1.2 High Demand for Analytical Testing of Biosimilars and Biologics
  • 5.2 Key Market Restraints:
    • 5.2.1 High Cost Associated to Bioanalytical Testing Services
  • 5.3 Key Market Opportunities
    • 5.3.1 Uninterrupted Growth of Pharmaceuticals Industry
  • 5.4 Future Trends
    • 5.4.1 Rising Drug Discovery and Development Activities for Emerging and Rare Diseases
  • 5.5 Impact Analysis:

6. Bioanalytical Testing Services Market - Asia Pacific Market Analysis

  • 6.1 Bioanalytical Testing Services Market Revenue (US$ Mn), 2022 - 2030

7. Asia Pacific Bioanalytical Testing Services Market - Revenue and Forecast to 2030 - by Services

  • 7.1 Overview
  • 7.2 Bioanalytical Testing Services Market Revenue Share, by Services 2022 & 2030 (%)
  • 7.3 Pharmacokinetics
    • 7.3.1 Overview
    • 7.3.2 Pharmacokinetics: Bioanalytical Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.4 Biomarkers
    • 7.4.1 Overview
    • 7.4.2 Biomarkers: Bioanalytical Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.5 Immunogenicity
    • 7.5.1 Overview
    • 7.5.2 Immunogenicity: Bioanalytical Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.6 Virology Testing
    • 7.6.1 Overview
    • 7.6.2 Virology Testing: Bioanalytical Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
      • 7.6.2.1 In-Vitro Virology Testing
        • 7.6.2.1.1 Overview
      • 7.6.2.2 In-Vitro Virology Testing: Bioanalytical Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
    • 7.6.3 In-Vivo Virology Testing
      • 7.6.3.1 Overview
      • 7.6.3.2 In-Vivo Virology Testing: Bioanalytical Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.7 Cell-Based Assays
    • 7.7.1 Overview
    • 7.7.2 Cell-Based Assays: Bioanalytical Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.8 Others
    • 7.8.1 Overview
    • 7.8.2 Others: Bioanalytical Testing Services Market - Revenue and Forecast to 2030 (US$ Million)

8. Asia Pacific Bioanalytical Testing Services Market - Revenue and Forecast to 2030 - by Disease Indication

  • 8.1 Overview
  • 8.2 Bioanalytical Testing Services Market Revenue Share, by Disease Indication 2022 & 2030 (%)
  • 8.3 Cardiovascular
    • 8.3.1 Overview
    • 8.3.2 Cardiovascular: Bioanalytical Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.4 Neurological Diseases
    • 8.4.1 Overview
    • 8.4.2 Neurological Diseases: Bioanalytical Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.5 Autoimmune Disorders
    • 8.5.1 Overview
    • 8.5.2 Autoimmune Disorders: Bioanalytical Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.6 Respiratory Diseases
    • 8.6.1 Overview
    • 8.6.2 Respiratory Diseases: Bioanalytical Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.7 Metabolic Disorders
    • 8.7.1 Overview
    • 8.7.2 Metabolic Disorders: Bioanalytical Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.8 Oncology
    • 8.8.1 Overview
    • 8.8.2 Oncology: Bioanalytical Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.9 Sexual Health
    • 8.9.1 Overview
    • 8.9.2 Sexual Health: Bioanalytical Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.10 Bone Disease
    • 8.10.1 Overview
    • 8.10.2 Bone Disease: Bioanalytical Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.11 Others
    • 8.11.1 Overview
    • 8.11.2 Others: Bioanalytical Testing Services Market - Revenue and Forecast to 2030 (US$ Million)

9. Asia Pacific Bioanalytical Testing Services Market - Revenue and Forecast to 2030 - by End User

  • 9.1 Overview
  • 9.2 Bioanalytical Testing Services Market Revenue Share, by End User 2022 & 2030 (%)
  • 9.3 Pharmaceutical and Biopharmaceutical Companies
    • 9.3.1 Overview
    • 9.3.2 Pharmaceutical and Biopharmaceutical Companies: Bioanalytical Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
  • 9.4 Contract Research Organization (CRO)
    • 9.4.1 Overview
    • 9.4.2 Contract Research Organization (CRO): Bioanalytical Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
  • 9.5 Contract Development And Manufacturing Organization (CDMO)
    • 9.5.1 Overview
    • 9.5.2 Contract Development and Manufacturing Organization (CDMO): Bioanalytical Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
  • 9.6 Others
    • 9.6.1 Overview
    • 9.6.2 Others: Bioanalytical Testing Services Market - Revenue and Forecast to 2030 (US$ Million)

10. Asia Pacific Bioanalytical Testing Services Market - Country Analysis

  • 10.1 Asia Pacific Bioanalytical Testing Services Market, Revenue and Forecast to 2030
    • 10.1.1 Overview
      • 10.1.1.1 Asia Pacific Bioanalytical Testing Services Market by Country
      • 10.1.1.2 China
        • 10.1.1.2.1 Overview
        • 10.1.1.2.2 China Bioanalytical Testing Services Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.1.1.2.3 China Bioanalytical Testing Services Market, by Services
        • 10.1.1.2.3.1 China Bioanalytical Testing Services Market, by Virology Testing
        • 10.1.1.2.4 China Bioanalytical Testing Services Market, by Disease Indication
        • 10.1.1.2.5 China Bioanalytical Testing Services Market, by End User
      • 10.1.1.3 Japan
        • 10.1.1.3.1 Overview
        • 10.1.1.3.2 Japan Bioanalytical Testing Services Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.1.1.3.3 Japan Bioanalytical Testing Services Market, by Services
        • 10.1.1.3.3.1 Japan Bioanalytical Testing Services Market, by Virology Testing
        • 10.1.1.3.4 Japan Bioanalytical Testing Services Market, by Disease Indication
        • 10.1.1.3.5 Japan Bioanalytical Testing Services Market, by End User
      • 10.1.1.4 India
        • 10.1.1.4.1 Overview
        • 10.1.1.4.2 India Bioanalytical Testing Services Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.1.1.4.3 India Bioanalytical Testing Services Market, by Services
        • 10.1.1.4.3.1 India Bioanalytical Testing Services Market, by Virology Testing
        • 10.1.1.4.4 India Bioanalytical Testing Services Market, by Disease Indication
        • 10.1.1.4.5 India Bioanalytical Testing Services Market, by End User
      • 10.1.1.5 Australia
        • 10.1.1.5.1 Overview
        • 10.1.1.5.2 Australia Bioanalytical Testing Services Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.1.1.5.3 Australia Bioanalytical Testing Services Market, by Services
        • 10.1.1.5.3.1 Australia Bioanalytical Testing Services Market, by Virology Testing
        • 10.1.1.5.4 Australia Bioanalytical Testing Services Market, by Disease Indication
        • 10.1.1.5.5 Australia Bioanalytical Testing Services Market, by End User
      • 10.1.1.6 South Korea
        • 10.1.1.6.1 Overview
        • 10.1.1.6.2 South Korea Bioanalytical Testing Services Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.1.1.6.3 South Korea Bioanalytical Testing Services Market, by Services
        • 10.1.1.6.3.1 South Korea Bioanalytical Testing Services Market, by Virology Testing
        • 10.1.1.6.4 South Korea Bioanalytical Testing Services Market, by Disease Indication
        • 10.1.1.6.5 South Korea Bioanalytical Testing Services Market, by End User
      • 10.1.1.7 Rest of Asia Pacific
        • 10.1.1.7.1 Overview
        • 10.1.1.7.2 Rest of Asia Pacific Bioanalytical Testing Services Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.1.1.7.3 Rest of Asia Pacific Bioanalytical Testing Services Market, by Services
        • 10.1.1.7.3.1 Rest of Asia Pacific Bioanalytical Testing Services Market, by Virology Testing
        • 10.1.1.7.4 Rest of Asia Pacific Bioanalytical Testing Services Market, by Disease Indication
        • 10.1.1.7.5 Rest of Asia Pacific Bioanalytical Testing Services Market, by End User

11. Bioanalytical Testing Services Market Industry Landscape

  • 11.1 Overview
  • 11.2 Growth Strategies in the Bioanalytical Testing Services Market
  • 11.3 Inorganic Growth Strategies
    • 11.3.1 Overview
  • 11.4 Organic Growth Strategies
    • 11.4.1 Overview

12. Company Profiles

  • 12.1 SGS SA
    • 12.1.1 Key Facts
    • 12.1.2 Business Description
    • 12.1.3 Products and Services
    • 12.1.4 Financial Overview
    • 12.1.5 SWOT Analysis
    • 12.1.6 Key Developments
  • 12.2 Pharmaron Beijing Co Ltd
    • 12.2.1 Key Facts
    • 12.2.2 Business Description
    • 12.2.3 Products and Services
    • 12.2.4 Financial Overview
    • 12.2.5 SWOT Analysis
    • 12.2.6 Key Developments
  • 12.3 Element Materials Technology Group Ltd
    • 12.3.1 Key Facts
    • 12.3.2 Business Description
    • 12.3.3 Products and Services
    • 12.3.4 Financial Overview
    • 12.3.5 SWOT Analysis
    • 12.3.6 Key Developments
  • 12.4 Charles River Laboratories International Inc
    • 12.4.1 Key Facts
    • 12.4.2 Business Description
    • 12.4.3 Products and Services
    • 12.4.4 Financial Overview
    • 12.4.5 SWOT Analysis
    • 12.4.6 Key Developments
  • 12.5 Eurofins Scientific SE
    • 12.5.1 Key Facts
    • 12.5.2 Business Description
    • 12.5.3 Products and Services
    • 12.5.4 Financial Overview
    • 12.5.5 SWOT Analysis
    • 12.5.6 Key Developments
  • 12.6 Labcorp Drug Development Inc
    • 12.6.1 Key Facts
    • 12.6.2 Business Description
    • 12.6.3 Products and Services
    • 12.6.4 Financial Overview
    • 12.6.5 SWOT Analysis
    • 12.6.6 Key Developments
  • 12.7 Syneos Health Inc
    • 12.7.1 Key Facts
    • 12.7.2 Business Description
    • 12.7.3 Products and Services
    • 12.7.4 Financial Overview
    • 12.7.5 SWOT Analysis
    • 12.7.6 Key Developments
  • 12.8 ICON Plc
    • 12.8.1 Key Facts
    • 12.8.2 Business Description
    • 12.8.3 Products and Services
    • 12.8.4 Financial Overview
    • 12.8.5 SWOT Analysis
    • 12.8.6 Key Developments
  • 12.9 Intertek Group Plc
    • 12.9.1 Key Facts
    • 12.9.2 Business Description
    • 12.9.3 Products and Services
    • 12.9.4 Financial Overview
    • 12.9.5 SWOT Analysis
    • 12.9.6 Key Developments

13. Appendix

  • 13.1 About Us
  • 13.2 Glossary of Terms

List Of Tables

  • Table 1. Asia Pacific Bioanalytical Testing Services Market Segmentation
  • Table 2. China Bioanalytical Testing Services Market Revenue And Forecast to 2030 (US$ Mn) - Services
  • Table 3. China Bioanalytical Testing Services Market Revenue And Forecast to 2030 (US$ Mn) - Virology Testing
  • Table 4. China Bioanalytical Testing Services Market Revenue And Forecast to 2030 (US$ Mn) - Disease Indication
  • Table 5. China Bioanalytical Testing Services Market Revenue And Forecast to 2030 (US$ Mn) - End User
  • Table 6. Japan Bioanalytical Testing Services Market Revenue And Forecast to 2030 (US$ Mn) - Services
  • Table 7. Japan Bioanalytical Testing Services Market Revenue And Forecast to 2030 (US$ Mn) - Virology Testing
  • Table 8. Japan Bioanalytical Testing Services Market Revenue And Forecast to 2030 (US$ Mn) - Disease Indication
  • Table 9. Japan Bioanalytical Testing Services Market Revenue And Forecast to 2030 (US$ Mn) - End User
  • Table 10. India Bioanalytical Testing Services Market Revenue And Forecast to 2030 (US$ Mn) - Services
  • Table 11. India Bioanalytical Testing Services Market Revenue And Forecast to 2030 (US$ Mn) - Virology Testing
  • Table 12. India Bioanalytical Testing Services Market Revenue And Forecast to 2030 (US$ Mn) - Disease Indication
  • Table 13. India Bioanalytical Testing Services Market Revenue And Forecast to 2030 (US$ Mn) - End User
  • Table 14. Australia Bioanalytical Testing Services Market Revenue And Forecast to 2030 (US$ Mn) - Services
  • Table 15. Australia Bioanalytical Testing Services Market Revenue And Forecast to 2030 (US$ Mn) - Virology Testing
  • Table 16. Australia Bioanalytical Testing Services Market Revenue And Forecast to 2030 (US$ Mn) - Disease Indication
  • Table 17. Australia Bioanalytical Testing Services Market Revenue And Forecast to 2030 (US$ Mn) - End User
  • Table 18. South Korea Bioanalytical Testing Services Market Revenue And Forecast to 2030 (US$ Mn) - Services
  • Table 19. South Korea Bioanalytical Testing Services Market Revenue And Forecast to 2030 (US$ Mn) - Virology Testing
  • Table 20. South Korea Bioanalytical Testing Services Market Revenue And Forecast to 2030 (US$ Mn) - Disease Indication
  • Table 21. South Korea Bioanalytical Testing Services Market Revenue And Forecast to 2030 (US$ Mn) - End User
  • Table 22. Rest of Asia Pacific Bioanalytical Testing Services Market Revenue And Forecast to 2030 (US$ Mn) - Services
  • Table 23. Rest of Asia Pacific Bioanalytical Testing Services Market Revenue And Forecast to 2030 (US$ Mn) - Virology Testing
  • Table 24. Rest of Asia Pacific Bioanalytical Testing Services Market Revenue And Forecast to 2030 (US$ Mn) - Disease Indication
  • Table 25. Rest of Asia Pacific Bioanalytical Testing Services Market Revenue And Forecast to 2030 (US$ Mn) - End User
  • Table 26. Recent Inorganic Growth Strategies in the Bioanalytical Testing Services Market
  • Table 27. Recent Organic Growth Strategies in the Bioanalytical Testing Services Market
  • Table 28. Glossary of Terms, Asia Pacific Bioanalytical Testing Services Market

List Of Figures

  • Figure 1. Asia Pacific Bioanalytical Testing Services Market Segmentation, By Country
  • Figure 2. Asia Pacific - PEST Analysis
  • Figure 3. Asia Pacific Bioanalytical Testing Services Market - Key Industry Dynamics
  • Figure 4. Impact Analysis of Drivers and Restraints
  • Figure 5. Asia Pacific Bioanalytical Testing Services Market Revenue (US$ Mn), 2022 - 2030
  • Figure 6. Asia Pacific Bioanalytical Testing Services Market Revenue Share, by Services 2022 & 2030 (%)
  • Figure 7. Pharmacokinetics: Bioanalytical Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 8. Biomarkers: Bioanalytical Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 9. Immunogenicity: Bioanalytical Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 10. Virology Testing: Bioanalytical Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 11. In-Vitro Virology Testing: Bioanalytical Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 12. In-Vivo Virology Testing: Bioanalytical Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 13. Cell-Based Assays: Bioanalytical Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 14. Others: Bioanalytical Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 15. Asia Pacific Bioanalytical Testing Services Market Revenue Share, by Disease Indication 2022 & 2030 (%)
  • Figure 16. Cardiovascular: Bioanalytical Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 17. Neurological Diseases: Bioanalytical Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 18. Autoimmune Disorders: Bioanalytical Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 19. Respiratory Diseases: Bioanalytical Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 20. Metabolic Disorders: Bioanalytical Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 21. Oncology: Bioanalytical Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 22. Sexual Health: Bioanalytical Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 23. Bone Disease: Bioanalytical Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 24. Others: Bioanalytical Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 25. Asia Pacific Bioanalytical Testing Services Market Revenue Share, by End User 2022 & 2030 (%)
  • Figure 26. Pharmaceutical and Biopharmaceutical Companies: Bioanalytical Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 27. Contract Research Organization (CRO): Bioanalytical Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 28. Contract Development and Manufacturing Organization (CDMO): Bioanalytical Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 29. Others: Bioanalytical Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 30. Asia Pacific Bioanalytical Testing Services Market, by Country, 2022 ($ Million)
  • Figure 31. Asia Pacific Bioanalytical Testing Services Market, By Key Countries, 2022 And 2030 (%)
  • Figure 32. China Bioanalytical Testing Services Market Revenue And Forecast to 2030 (US$ Mn)
  • Figure 33. Japan Bioanalytical Testing Services Market Revenue And Forecast to 2030 (US$ Mn)
  • Figure 34. India Bioanalytical Testing Services Market Revenue And Forecast to 2030 (US$ Mn)
  • Figure 35. Australia Bioanalytical Testing Services Market Revenue And Forecast to 2030 (US$ Mn)
  • Figure 36. South Korea Bioanalytical Testing Services Market Revenue And Forecast to 2030 (US$ Mn)
  • Figure 37. Rest of Asia Pacific Bioanalytical Testing Services Market Revenue And Forecast to 2030 (US$ Mn)
  • Figure 38. Growth Strategies in the Bioanalytical Testing Services Market